EG
NYSE Everest Group, Ltd.$389.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $389.10, $0.01 below the day’s high of $389.11
- YTD change
- +14.66%
- vs 20-day SMA
- +4.99%
- vs 200-day SMA
- +11.18%
Price ranges
Price & Performance
+37.61 (+10.70%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 6.9% away from all-time highs of $417.92
- EG is up 15% since the beginning of the year
- EG is up 14% over the past 12 months
- EG is up 2% over the past 1 month
- 6% of all EG investors are betting against EG
- Number of investors short EG has gone down 8% versus last month
EG reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +11.4%.
- Previous minute
- +$0.00
- Last hour
- -$0.90
- Last 5 days
- +4.29%
- vs 8-day SMA
- +4.64%
No alerts for EG in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Everest Group Ltd. is a holding company, which engages in the provision of reinsurance and insurance services. It operates through the following segments: Reinsurance, and Insurance. The Reinsurance segment writes property and casualty reinsurance and specialty lines of business, including marine, aviation, surety, and accident and health business, on both a treaty and facultative basis, through reinsurance brokers, as well as directly with ceding companies primarily within the U.S. The Insurance segment writes property and casualty insurance directly and through brokers, surplus lines brokers, and general agents within the U.S., Canada, and Europe. The company was founded in 1999 and is headquartered in Hamilton, Bermuda.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.